dc.contributor.author | Vráblíková, Alena | |
dc.contributor.author | Fojtíková, Martina | |
dc.contributor.author | Héžová, Renata | |
dc.contributor.author | Šimečková, Pavlína | |
dc.contributor.author | Brezáni, Veronika | |
dc.contributor.author | Straková, Nicol | |
dc.contributor.author | Fraiberk, Martin | |
dc.contributor.author | Kotouček, Jan | |
dc.contributor.author | Mašek, Josef | |
dc.contributor.author | Pšikal, Ivan | |
dc.date.accessioned | 2024-02-21T17:10:56Z | |
dc.date.available | 2024-02-21T17:10:56Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/2261 | |
dc.description.abstract | Ultraviolet irradiation is an effective method of virus and bacteria inactivation. The dose of UV-C light necessary for baculovirus inactivation by measurement of fluorescent GFP protein produced by baculovirus expression system after the irradiation of baculovirus culture in doses ranging from 3.5 to 42 J/m2 was determined. At a dose of 36.8 J/m2, only 0.5% of GFP-expressing cells were detected by flow cytometry and confocal microscopy. The stability of purified VP1-PCV2bCap protein produced by baculovirus expression system was analyzed after the irradiation at doses ranging from 3.5 to 19.3 J/m2. Up to the dose of 11 J/m2, no significant effect of UV-C light on the stability of VP1-PCV2bCap was detected. We observed a dose-dependent increase in VP1-PCV2bCap-specific immune response in BALB/c mice immunized by recombinant protein sterilized by irradiation in dose 11 J/m2 with no significant difference between vaccines sterilized by UV-C light and filtration. A substantial difference in the production of VP1-PCV2bCap specific IgG was observed in piglets immunized with VP1-PCV2bCap sterilized by UV-C in comparison with protein sterilized by filtration in combination with the inactivation of baculovirus by binary ethylenimine. UV-C irradiation represents an effective method for vaccine sterilization, where commonly used methods of sterilization are not possible. | en |
dc.language.iso | en | |
dc.relation.url | https://doi.org/10.1038/s41598-023-46791-9 | |
dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.title | UV-C irradiation as an effective tool for sterilization of porcine chimeric VP1-PCV2bCap recombinant vaccine | en |
dcterms.accessRights | openAccess | |
dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
dc.date.updated | 2024-12-27T15:40:46Z | |
dc.subject.keyword | UV-C | en |
dc.subject.keyword | irradiation | en |
dc.subject.keyword | VP1-PCV2bCap | en |
dc.subject.keyword | vaccine | en |
dc.subject.keyword | virus | en |
dc.identifier.eissn | 2045-2322 | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/UK/COOP/COOP | |
dc.date.embargoStartDate | 2024-12-27 | |
dc.type.obd | 73 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dc.identifier.doi | 10.1038/s41598-023-46791-9 | |
dc.identifier.utWos | 001101369900095 | |
dc.identifier.eidScopus | 2-s2.0-85175966726 | |
dc.identifier.obd | 645106 | |
dc.identifier.riv | RIV/00216208:11310/23:10477443 | |
dc.identifier.pubmed | 37935819 | |
dc.subject.rivPrimary | 10000::10600::10607 | |
dcterms.isPartOf.name | Scientific Reports | |
dcterms.isPartOf.issn | 2045-2322 | |
dcterms.isPartOf.journalYear | 2023 | |
dcterms.isPartOf.journalVolume | 13 | |
dcterms.isPartOf.journalIssue | 1 | |
uk.faculty.primaryId | 115 | |
uk.faculty.primaryName | Přírodovědecká fakulta | cs |
uk.faculty.primaryName | Faculty of Science | en |
uk.department.primaryId | 1034 | |
uk.department.primaryName | Katedra genetiky a mikrobiologie | cs |
uk.department.primaryName | Department of Genetics and Microbiology | en |
dc.type.obdHierarchyCs | ČLÁNEK V ČASOPISU::článek v časopisu::původní článek | cs |
dc.type.obdHierarchyEn | JOURNAL ARTICLE::journal article::original article | en |
dc.type.obdHierarchyCode | 73::152::206 | en |
uk.displayTitle | UV-C irradiation as an effective tool for sterilization of porcine chimeric VP1-PCV2bCap recombinant vaccine | en |